Patents by Inventor Marieke Veurink

Marieke Veurink has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL STABLE HIGH-CONCENTRATION FORMULATION FOR ANTI-FXIa ANTIBODIES
    Publication number: 20210292434
    Abstract: The present invention refers to novel liquid pharmaceutical high-concentration formulations particularly suitable for subcutaneous administration comprising human antibodies against coagulation factor FXIa as active ingredient, especially those described in WO2013167669, which are stable as liquid formulations over a long period. The invention also refers to lyophilizates of the specified liquid formulation with reduced reconstitution time and also to the use of these formulations in the therapy and prophylaxis of thrombotic or thromboembolic disorder.
    Type: Application
    Filed: July 5, 2019
    Publication date: September 23, 2021
    Applicant: Bayer Aktiengesellschaft
    Inventors: Niklas GOMBERT, Marieke VEURINK, Alexander KLAK, Stefan Christian SCHNEID, Stefan HEKE, Matthias PLITZKO
  • NOVEL STABLE FORMULATION FOR FXIA ANTIBODIES
    Publication number: 20190367636
    Abstract: The present invention refers to novel liquid pharmaceutical formulations comprising human antibody against coagulation factor FXIa as active ingredient. The invention also refers to lyophilizates of the specified liquid formulation and also to the use thereof in the therapy and prophylaxis of thrombotic or thromboembolic disorder.
    Type: Application
    Filed: January 16, 2018
    Publication date: December 5, 2019
    Applicant: Bayer Pharma Aktiengesellschaft
    Inventors: Carsten OLBRICH, Thomas TRILL, Marieke VEURINK
  • Bevacizumab formulations with lower aggregation propensity, comprising corticosteroid anti-inflammatory drugs
    Patent number: 9155745
    Abstract: The present invention is directed to combination formulations of monoclonal antibodies with anti-inflammatory agents, related methods and uses thereof.
    Type: Grant
    Filed: June 9, 2010
    Date of Patent: October 13, 2015
    Assignee: UNIVERSITE DE GENEVE
    Inventors: Robert Gurny, Cinzia Stella, Cyrus Tabatabay, Marieke Veurink, Constantin Pournaras
  • STABILIZED ANTIBODY PREPARATIONS AND USES THEREOF
    Publication number: 20130028920
    Abstract: The present invention is directed to stabilized intact antibody formulations, related methods and uses thereof. In particular, the invention relates to a method of stabilizing an intact antibody in a liquid carrier.
    Type: Application
    Filed: March 31, 2011
    Publication date: January 31, 2013
    Applicant: UNIVERSITE DE GENEVE
    Inventors: Robert Gurny, Leonardo Scapozza, Yvonne Westermaier, Marieke Veurink
  • STABILIZED ANTIBODY PREPARATIONS AND USES THEREOF
    Publication number: 20130017197
    Abstract: The present invention is directed to stabilized intact antibody formulations, related methods and uses thereof. In particular, the invention relates to a method of stabilizing an intact antibody in a liquid carrier.
    Type: Application
    Filed: March 31, 2011
    Publication date: January 17, 2013
    Applicant: UNIVERSITE DE GENEVE
    Inventors: Robert Gurny, Leonardo Scapozza, Yvonne Westermaier, Marieke Veurink
  • Antibody Formulations and Use Thereof
    Publication number: 20100316638
    Abstract: The present invention is directed to combination formulations of monoclonal antibodies with anti-inflammatory agents, related methods and uses thereof.
    Type: Application
    Filed: June 9, 2010
    Publication date: December 16, 2010
    Applicant: UNIVERSITE DE GENEVE
    Inventors: Robert Gurny, Cinzia Stella, Cyrus Tabatabay, Marieke Veurink, Constantin Pournaras